Metabolic Changes in Synaptosomes in an Animal Model of Schizophrenia Revealed by 1H and 1H,13C NMR Spectroscopy

Abstract

Synaptosomes are isolated nerve terminals that contain synaptic components, including neurotransmitters, metabolites, adhesion/fusion proteins, and nerve terminal receptors. The essential role of synaptosomes in neurotransmission has stimulated keen interest in understanding both their proteomic and metabolic composition. Mass spectrometric (MS) quantification of synaptosomes has illuminated their proteomic composition, but the determination of the metabolic composition by MS has been met with limited success. In this study, we report a proof-of-concept application of one- and two-dimensional nuclear magnetic resonance (NMR) spectroscopy for analyzing the metabolic composition of synaptosomes. We utilize this approach to compare the metabolic composition synaptosomes from a wild-type rat with that from a newly generated genetic rat model (Disc1 svΔ2), which qualitatively recapitulates clinically observed early DISC1 truncations associated with schizophrenia. This study demonstrates the feasibility of using NMR spectroscopy to identify and quantify metabolites within synaptosomal fractions.

NMR Metabolomics in Serum Fingerprinting of Schizophrenia Patients in a Serbian Cohort

“…However, NMR analyses offer high reproducibility and quantitative accuracy using intact biospecimens without the need for separation [8]. Previous metabolomic and lipidomic analyses of fluid (blood and urine) samples of patients with schizophrenia [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] led to the detection of metabolites as potential biomarkers. NMR-based metabolomics of patient serum samples offered 59 potential biomarkers for schizophrenia [9][10][11][12][13][14][15].…”